Radiotherapy in the management of localized primary cutaneous B-cell lymphoma

被引：7
|
作者：
Pashtan, Itai [1 ]
Mauch, Peter M. [2 ,3 ]
Chen, Yu-Hui [4 ]
Dorfman, David M. [5 ]
Silver, Barbara [2 ,3 ]
Ng, Andrea K. [2 ,3 ]
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Dana Farber Brigham & Womens Canc Ctr, Dept Radiat Oncol, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 04期
关键词：
Primary cutaneous B-cell lymphoma; prognosis; radiation; dose; local control; TREATMENT-OF-CANCER; WHO-EORTC CLASSIFICATION; EUROPEAN-ORGANIZATION; UNITED-STATES; PROPOSAL; SYSTEM;
D O I：
10.3109/10428194.2012.723707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The optimal therapy and radiation dose for patients with localized primary cutaneous B-cell lymphoma (PCBCL) are unknown. We retrospectively identified 23 patients with localized (T1-T2) PCBCL treated with definitive radiation to doses ranging from 30 to 44 Gy (median, 36 Gy). With a median follow-up of 4.8 years, the 5-year overall survival rate was 100%, the relapse-free survival rate was 71% (95% confidence interval, 46-86%) and there were no local recurrences, suggesting that radiotherapy to a dose of 30 Gy may be sufficient for cure.
引用
收藏
页码：726 / 730
页数：5
相关论文
共 50 条
  • [1] Radiotherapy for Management of Localized Primary Cutaneous B-cell Lymphoma
    Pashtan, I. M.
    Mauch, P. M.
    Chen, Y.
    Silver, B.
    Ng, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S630 - S630
  • [2] Radiotherapy in indolent primary cutaneous B-cell lymphoma
    De Felice, Francesca
    Grapulin, Lavinia
    Pieroni, Alessandra
    Salerno, Francesca
    D'Elia, Gianna Maria
    Pulsoni, Alessandro
    Musio, Daniela
    Tombolini, Vincenzo
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 610 - 610
  • [3] TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA WITH LOCAL RADIOTHERAPY
    ZEMTSOV, A
    CAMISA, C
    CUTIS, 1990, 45 (06): : 435 - 438
  • [4] Effectiveness analysis of radiotherapy in primary cutaneous B-cell lymphoma
    Eich, HT
    Eich, D
    Stützer, H
    Micke, O
    Casper, C
    Krieg, T
    Müller, RP
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 37 - 37
  • [5] Primary cutaneous B-cell lymphoma
    Bogle, MA
    Riddle, CC
    Triana, EM
    Jones, D
    Duvic, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (03) : 479 - 484
  • [6] Primary cutaneous B-cell lymphoma
    Clayton, AS
    McCullough, M
    Barekman, CL
    CUTIS, 1998, 62 (02): : 69 - 72
  • [7] Primary Cutaneous Large B-Cell Lymphoma, Leg Type, Localized on the Dorsum
    Patrizia, A.
    Raonea, B.
    Sabattinib, E.
    Guriolia, C.
    Pileri, A., Jr.
    D'Acuntoa, C.
    CASE REPORTS IN DERMATOLOGY, 2009, 1 (01): : 87 - 92
  • [8] Urticarial reaction localized to primary cutaneous B-cell lymphoma induced by rituximab
    Rimond, O.
    Morice, C.
    Moreau, A.
    Comoz, F.
    Verneuil, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 60 - 60
  • [9] Efficacy of radiotherapy in primary cutaneous B-cell lymphoma. Prognostic factors
    Caballero, P.
    Cabeza, A.
    Murillo, T.
    Colmenero, M.
    Drove, N.
    Manas, A.
    Lanzos, E.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S400 - S400
  • [10] De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma
    Oertel, M.
    Elsayad, K.
    Weishaupt, C.
    Steinbrink, K.
    Eich, H. T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S493 - S493
12345